Holen Sie sich die Stockscreener-App
37.92
1.46%
0.365
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HROW?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$37.56
Offen:
$37.68
24-Stunden-Volumen:
124.48K
Relative Volume:
0.18
Marktkapitalisierung:
$1.40B
Einnahmen:
$154.15M
Nettoeinkommen (Verlust:
$-33.58M
KGV:
-39.51
EPS:
-0.96
Netto-Cashflow:
$-20.74M
1W Leistung:
-1.06%
1M Leistung:
-20.90%
6M Leistung:
+53.86%
1J Leistung:
-15.42%
1-Tages-Spanne:
$37.31
$38.53
1-Wochen-Bereich:
$36.20
$39.30
52-Wochen-Spanne:
$20.85
$54.19
Harrow Inc Stock (HROW) Company Profile
Firmenname
Harrow Inc
Sektor
Telefon
615.733.4731
Adresse
1A BURTON HILLS BLVD, NASHVILLE, CA
Vergleichen Sie HROW mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
37.85 | 1.39B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
142.84 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.41 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.2433 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.09 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
447.64 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-12 | Eingeleitet | BTIG Research | Buy |
| 2025-06-10 | Eingeleitet | William Blair | Outperform |
| 2025-02-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-04 | Bestätigt | B. Riley Securities | Buy |
| 2024-04-11 | Eingeleitet | Craig Hallum | Buy |
| 2022-09-08 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-09-24 | Eingeleitet | Aegis Capital | Buy |
| 2021-07-02 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Harrow Inc Aktie (HROW) Neueste Nachrichten
Best data tools to analyze Harrow Inc. stockWeekly Trade Analysis & Verified Trade Idea Suggestions - newser.com
Can Harrow Inc. stock sustain market leadershipWeekly Risk Report & AI Forecast for Swing Trade Picks - newser.com
How Harrow Inc. stock reacts to global recession fearsProfit Target & Weekly Market Pulse Alerts - newser.com
Why Harrow Inc. stock is in analyst buy zone2025 Winners & Losers & Risk Managed Investment Strategies - newser.com
What insider trading reveals about Harrow Inc. stock2025 Pullback Review & Fast Entry High Yield Stock Tips - newser.com
What risks investors should watch in Harrow Inc. stockWeekly Trade Analysis & Reliable Entry Point Alerts - newser.com
Will Harrow Inc. stock pay special dividends2025 Bull vs Bear & AI Powered Market Trend Analysis - newser.com
Corrado Advisors LLC Purchases Shares of 7,366 Harrow, Inc. $HROW - MarketBeat
Custom watchlist performance reports with Harrow Inc.Portfolio Profit Report & Low Risk Profit Maximizing Plans - newser.com
What is the fair value of Harrow Inc. stock now2025 Price Targets & Free Verified High Yield Trade Plans - newser.com
Analyzing Harrow Inc. with risk reward ratio chartsPortfolio Profit Report & Trade Opportunity Analysis - newser.com
Key resistance and support levels for Harrow Inc.July 2025 Setups & Verified Swing Trading Watchlists - newser.com
Should you hold or exit Harrow Inc. now2025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com
D.A. Davidson & CO. Sells 13,255 Shares of Harrow, Inc. $HROW - MarketBeat
Harrow, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Indicators - Markets Mojo
Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025 - The Manila Times
Harrow (NASDAQ: HROW) sets third-quarter results Nov 10; call and webcast Nov 11 - Stock Titan
Kornitzer Capital Management Inc. KS Acquires New Position in Harrow, Inc. $HROW - MarketBeat
Bleakley Financial Group LLC Makes New Investment in Harrow, Inc. $HROW - MarketBeat
Will Harrow Inc. stock keep outperforming rivalsDollar Strength & Real-Time Market Trend Scan - newser.com
Weiss Ratings Reaffirms "Sell (E+)" Rating for Harrow (NASDAQ:HROW) - MarketBeat
Sundram Fasteners Limited (SUNDRMFAST) to Launch New Product LineChart Pattern Recognition & Double Or Triple Investment - earlytimes.in
Finanzdaten der Harrow Inc-Aktie (HROW)
Umsatz
Nettogewinn
Free Cashflow
ENV
Harrow Inc-Aktie (HROW) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Jun 10 '25 |
Sale |
30.80 |
15,000 |
462,033 |
90,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 09 '25 |
Sale |
30.37 |
15,204 |
461,794 |
105,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 03 '25 |
Sale |
30.04 |
3,000 |
90,116 |
122,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 04 '25 |
Sale |
30.02 |
1,796 |
53,907 |
120,204 |
| Opaleye Management Inc. | 10% Owner |
May 12 '25 |
Sale |
25.90 |
10,000 |
258,959 |
130,000 |
| Opaleye Management Inc. | 10% Owner |
May 13 '25 |
Sale |
26.59 |
5,000 |
132,945 |
125,000 |
| BOLL ANDREW R. | Chief Financial Officer |
Apr 03 '25 |
Option Exercise |
0.00 |
346,500 |
0 |
914,589 |
| SAHAREK JOHN P. | CEO & President, ImprimisRx |
Apr 03 '25 |
Option Exercise |
0.00 |
277,200 |
0 |
576,863 |
| BAUM MARK L | Chief Executive Officer |
Apr 03 '25 |
Option Exercise |
0.00 |
762,300 |
0 |
2,899,825 |
| Opaleye Management Inc. | 10% Owner |
Mar 18 '25 |
Sale |
30.01 |
5,000 |
150,055 |
140,000 |
6.10%
1.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):